系统综述与荟萃分析:慢性难治性储袋炎的管理及基于证据的治疗算法
该系统综述检索MEDLINE和EMBASE(1966年至2016年2月),纳入21篇报告慢性储袋炎药物治疗后缓解率的研究;汇总缓解率为59%(95%CI 44-73),抗生素缓解率74%(95%CI 56-93,P<0.001),生物制剂缓解率53%(95%CI 30-76,P<0.001)。
要点
- 慢性难治性储袋炎药物治疗总体缓解率为59%(95%CI 44-73)。
- 抗生素显著诱导缓解,缓解率74%(95%CI 56-93,P<0.001)。
- 生物制剂显著诱导缓解,缓解率53%(95%CI 30-76,P<0.001)。
核心结论
- 慢性难治性储袋炎的治疗仍然困难且很大程度上是经验性的,需要更大规模的随机对照试验来帮助指导慢性储袋炎的管理。
研究设计与样本
- 系统计算机辅助检索在线文献数据库MEDLINE和EMBASE(1966年至2016年2月),纳入所有报告慢性储袋炎药物治疗后缓解率的原始研究,考虑所有研究设计;共21篇论文符合条件。
主要发现
- 所有研究合并结果显示,总体缓解率为59%(95%CI 44-73)。
- 抗生素显著诱导慢性储袋炎患者缓解,缓解率74%(95%CI 56-93,P<0.001)。
- 生物制剂显著诱导慢性储袋炎患者缓解,缓解率53%(95%CI 30-76,P<0.001)。
- 类固醇、铋剂、要素饮食和他克莫司均可诱导缓解,但未达到统计学显著性。
- 一项单研究中粪菌移植未发现能达到缓解。
关键数值与推荐
- 缓解定义依据各研究自身标准,缓解终点范围从15天到10周。
- 慢性储袋炎由各研究自行定义。
局限性
- 慢性难治性储袋炎的治疗仍然困难且很大程度上是经验性的。
- 需要更大规模的随机对照试验来帮助指导慢性储袋炎的管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Restorative proctocolectomy with ileal pouch anal anastomosis (IPAA) is considered the procedure of choice in patients with ulcerative colitis (UC) refractory to medical therapy. The incidence of pouchitis is 40% at 5 years. Ten to 15% of patients with pouchitis experience chronic pouchitis. AIM: To determine the efficacy of medical therapies for the treatment of chronic refractory pouchitis in patients undergoing IPAA for UC. METHODS: A systematic computer-assisted search of the on-line bibliographic database MEDLINE and EMBASE was performed between 1966 and February 2016. All original studies reporting remission rates following medical treatment for chronic pouchitis were included. All study designs were considered. Remission was defined according to the individual study. Remission endpoints ranged from 15 days to 10 weeks. Chronic pouchitis was defined by each study. RESULTS: Twenty-one papers were considered eligible. Results from all studies combined suggested that overall remission was obtained in 59% of patients (95% CI: 44-73%). Antibiotics significantly induced remission in patients with chronic pouchitis with 74% remission rate (95% CI:56-93%), (P < 0.001). Biologics significantly induced remission in patients with chronic pouchitis with 53% remission rate (95% CI:30-76%), (P < 0.001). Steroids, bismuth, elemental diet and tacrolimus all can induce remission but failed to achieve significance. Faecal microbiota transplantation in a single study was not found to achieve remission. CONCLUSIONS: Treatment of chronic refractory pouchitis remains difficult and is largely empirical. Larger randomised controlled trials will help aid the management of chronic pouchitis.
引用
- Segal JP, Ding NS, Worley G, et al. Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. Aliment Pharmacol Ther. 2016. PMID: 28008631. doi:10.1111/apt.13905
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。